766515-34-8

Basic information

• Product Name: 2-CHLORO-5-IODOPYRIDINE-3-CARBONITRILE
• Synonyms: 2-CHLORO-5-IODOPYRIDINE-3-CARBONITRILE;2-Chloro-5-iodo-3-pyridinecarbonitrile;3-Pyridinecarbonitrile, 2-chloro-5-iodo-
• CAS NO: 766515-34-8
• Molecular Formula: C₆H₂ClIN₂
• Molecular Weight: 264.45
• EINECS: 1312995-182-4
• Product Categories: cyanide| alkyl chloride|alkyl Iodine
• Mol File: 766515-34-8.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Density: 2.13
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 2-CHLORO-5-IODOPYRIDINE-3-CARBONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-5-IODOPYRIDINE-3-CARBONITRILE(766515-34-8)
• EPA Substance Registry System: 2-CHLORO-5-IODOPYRIDINE-3-CARBONITRILE(766515-34-8)

Safety Data

• Hazardous Substances Data: 766515-34-8(Hazardous Substances Data)

Usage

General Description

2-Chloro-5-iodopyridine-3-carbonitrile is a specialized chemical compound that belongs to the pyridine family, commonly used in the field of pharmaceuticals and chemical research. Characterized by its distinct structure containing chlorine, iodine and a carbonitrile group attached to a pyridine ring, it offers a range of possibilities for chemical reactions and transformations. As a chemical intermediate, its properties may allow the synthesis of complex compounds, often useful in medicinal chemistry or material science. The compound is generally available from chemical suppliers for use in laboratory or industrial settings.

Upstream product

• 6602-54-6 2-chloro-3-pyridinecarbonitrile 
• 20577-27-9 2-hydroxy-3-cyanopyridine 
• 766515-33-7 3-cyano-2-hydroxy-5-iodopyridine 

Downstream Products

• 766515-35-9 1-methyl-3-amino-5-iodo-1H-pyrazolo[3,4-b]pyridine 
• 1392151-89-1 5-(3,5-difluorophenyl sulfinyl)-1H-pyrazolo[3,4-b]pyrazin-3-amine 
• 1392151-92-6 5-[(3,5-difluorophenyl)sulfonyl]-1H-pyrazolo[3,4-b]pyrazin-3-amine 
• 1392151-76-6 1-(5-((3,5-difluorophenyl)thio)-1H-pyrazolo[3,4-b]pyridin-3-yl)-3-(4-(4-methylpiperazin-1-yl)phenyl)thiourea 
• 1392151-64-2 N-(5-((3,5-difluorophenyl)thio)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide 
• 1392151-65-3 N-(5-(3,5-difluorophenylthio)-1-(4-(4-methylpiperazine-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido) benzoyl)-1H-pyrazolo[3,4-b]pyrazine-3-yl)-4-(4-methylpiperazine-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzamide 
• 1392150-08-1 5-[(3,5-difluorophenyl)thio]-1H-pyrazolo[3,4-b]pyrazin-3-amine 
• 766515-38-2 1-methyl-3-(2,2-dimethyl-propionamido)-5-phenylethynyl-1H-pyrazolo[3,4-b]pyridine 
• 766515-39-3 (E)-1-methyl-3-(2,2-dimethyl-propionamido)-5-styryl-1H-pyrazolo[3,4-b]pyridine 
• 766515-40-6 1-methyl-3-(2,2-dimethyl-propionamido)-5-phenyl-1H-pyrazolo[3,4-b]pyridine 
• 766515-45-1 1-methyl-3-iodo-5-phenylethynyl-1H-pyrazolo[3,4-b]pyridine 
• 766515-42-8 1-methyl-3-amino-5-phenylethynyl-1H-pyrazolo[3,4-b]pyridine 

Relevant articles and documents

Derivatives of azaindoles or diazaindoles for treating pain

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING PAIN

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.